Anchored Immunotherapy
The Unmet Need
Despite their biological promise immune-modulating tumor-targeted therapies have been held back by toxicity, dosing and delivery challenges; specifically:
- Inability to keep the active drug localized
- Reduced efficacy due to rapid clearance and lower drug concentrations
- Increased systemic exposure and related toxicity
Our Solution
Anchored Immunotherapy offers the promise of better outcomes due to:
- Sustained local immune activation due to enhanced retention
- Reduced systemic side effects from drug leakage
- Fewer administrations to achieve therapeutic benefit
Prolonged antitumor immune activation
Minimal systemic side effects from drug leakage
